Search research articles
Contact Us
Filters
Showing results (311-320 of 325) with videos related to
Page
of 33
Sort By:
Leukemia
|
September 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
Daniel Hägerstrand, Blaž Oder, Diego Cortese, et al.
The New England Journal of Medicine
|
June 3, 2014
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
John C Byrd, Jennifer R Brown, Susan O'Brien, et al.
European Journal of Haematology
|
July 25, 2018
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
Massimo Gentile, Tait D Shanafelt, Francesca Romana Mauro, et al.
Cancer Immunology Research
|
June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Blood
|
April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Wei Ding, Betsy R LaPlant, Timothy G Call, et al.
Blood
|
June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia
Susan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Frontiers in Medicine
|
November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis
Solomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
Nature Medicine
|
January 9, 2023
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Erin M Parry, Ignaty Leshchiner, Romain Guièze, et al.
Blood
|
April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Geffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Plos Genetics
|
May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
Karin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 325) with videos related to
Sort By:
Page
of 33
Leukemia
|
September 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
Daniel Hägerstrand, Blaž Oder, Diego Cortese, et al.
The New England Journal of Medicine
|
June 3, 2014
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
John C Byrd, Jennifer R Brown, Susan O'Brien, et al.
European Journal of Haematology
|
July 25, 2018
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
Massimo Gentile, Tait D Shanafelt, Francesca Romana Mauro, et al.
Cancer Immunology Research
|
June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Blood
|
April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Wei Ding, Betsy R LaPlant, Timothy G Call, et al.
Blood
|
June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia
Susan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Frontiers in Medicine
|
November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis
Solomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
Nature Medicine
|
January 9, 2023
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Erin M Parry, Ignaty Leshchiner, Romain Guièze, et al.
Blood
|
April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Geffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Plos Genetics
|
May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
Karin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Page
of 33